How Visivra Works: The Mechanism Behind Six Eye Actives

Strip the marketing away and the mechanism behind this whole category is a single fact about the retina: the macula concentrates carotenoids, and it cannot make them. The yellow you can see in a dissected macula, and measure in a living eye as macular pigment optical density, is lutein and zeaxanthin that arrived through food.

Once there they do two things that can be measured. They absorb short-wavelength light before it reaches the photoreceptors, which is a filter effect. And they quench reactive oxygen species in a tissue that combines a very high oxygen supply, constant light exposure and a membrane chemistry that oxidises easily. The retina is, in that narrow sense, an unusually demanding place to keep intact.

The meta-analysis of macular pigment against visual function is the honest summary of what follows from that. Higher pigment associates most reliably with glare recovery and contrast measures, less reliably with acuity, which is the letter chart most people think of when they think about vision. A supplement in this category is not aimed at the letter chart.

The two non-carotenoids on this label work on a different part of the same tissue, and they are the two with real physiology rather than association behind them.

Vitamin A is structural to the act of seeing. Retinal binds to opsin to form rhodopsin, a photon isomerises it, the shape change opens a signal cascade, and the molecule is then recycled through the retinal pigment epithelium in what is called the visual cycle. Deficiency shows up first as poor dark adaptation, because rods have the least margin.

Zinc sits alongside that cycle. The review of zinc in the eye sets out its role as a cofactor for retinol dehydrogenase, the enzyme step in the visual cycle, and for antioxidant enzymes in the pigment epithelium. That is the argument for putting the two on the same label, and it is a coherent one.

Bilberry is the outlier in mechanism terms. Its anthocyanins are proposed to act on the ciliary muscle and on microcirculation rather than on the photoreceptors, which is why its trials measured accommodation and fatigue rather than retinal outcomes. It is on this label for a different job from the other five.

Everything above is dose-dependent and that is not a rhetorical point. Macular pigment rises in proportion to how much lutein reaches the serum. The one-year trial used lutein 10 mg and zeaxanthin 2 mg a day for one year, 115 young adults and measured the pigment going up. The screen-time trial used twice that, split into two doses a day.

So when a label names lutein without a figure, the mechanism described above is still real but you cannot tell whether this bottle engages it. That is the practical reason this desk prints the trial amounts on every page rather than treating the gap as a footnote. It is also why the label and amounts page exists as a page rather than as a paragraph.